LINDEINDIALinde India Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Linde India Limited manufactures and sells industrial and medical gases in India. It operates through Gases, Related Products and Services; and Project Engineering Division segments. The Gases, Related Products and Services segment produces and sells oxygen, nitrogen, and argon gases. This segment engages in the provision of pipeline gas supply to steel, glass, and chemical industries; liquefied gases through cryogenic tankers to various industrial sectors; and compressed gas in cylinders to fabrication, manufacturing, and construction industries. It offers gases, such as medical oxygen, synthetic air, and nitrous oxide for pharmaceutical use, as well as medical gas distribution systems to hospitals. The Project Engineering Division is involved in the design, engineering, manufacture, and commissioning of cryogenic and non-cryogenic air separation plants (ASUs), vacuum pressure swing adsorption (VPSA) units, and nitrogen plants; and the sale of distillation columns, cryogenic storage tanks, and vaporizers. It serves various industries, such as steel, automotive, pharma, metal fabrication, chemicals, food and beverage, solar panels, science and research, natural gas and oil refining, petrochemicals, fertilizers, electronics, and metal processing, as well as hospitals and healthcare establishments. The company was formerly known as BOC India Limited and changed its name to Linde India Limited in February 2013. Linde India Limited was incorporated in 1935 and is headquartered in Kolkata, India. Linde India Limited is a subsidiary of The BOC Group Limited.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on LINDEINDIA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 34/100)
- • Profit growth: -2.5% YoY
- • Valuation vs sector: P/E 88.0 vs sector 23.2
- • RSI: 28
- • MACD: bearish
Bull case
- • Revenue growth: 21.6% YoY
- • Debt/Equity: 0.02
- • Promoter holding: 78.0%
- • Volatility: 29% annualized
Bear case
- • Profit growth: -2.5% YoY
- • Valuation vs sector: P/E 88.0 vs sector 23.2
- • RSI: 28
- • MACD: bearish
Key risks
- • Momentum is fading versus the broader market
- • Profit growth: -2.5% YoY
- • Valuation vs sector: P/E 88.0 vs sector 23.2
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹161.78). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.